Results 221 to 230 of about 41,889,929 (253)
The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's Disease
ABSTRACT Objective To clarify the relative contributions of amyloid and tau to synaptic dysfunction in Alzheimer's disease (AD). Methods We included 109 cognitively unimpaired and impaired individuals from the Geneva Memory Center with available CSF synaptic biomarkers (neurogranin, SNAP‐25, GAP‐43). Participants were stratified according to amyloid (A)
Fausto Roveta +11 more
wiley +1 more source
A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone
ABSTRACT Objective Plasma p‐Tau217 leaves 30%–50% of patients in an indeterminate “gray zone” often requiring Aβ‐PET. We developed GRAD (Gatekeeper‐Reflex for Alzheimer's Disease), a two‐stage Aβ‐positivity prediction model to improve classification while reserving Aβ‐PET for residual uncertainty.
Harthik Parankusham +7 more
wiley +1 more source
Purification of MNase for Use in Ribosomal Profiling of High-Salinity Extremophiles. [PDF]
Gregorova P +3 more
europepmc +1 more source
Association between smartphone ownership, proficiency, and electronic money use among community-dwelling older adults: a cross-sectional study. [PDF]
Shimokihara S +12 more
europepmc +1 more source
Workflow for Accurate Measurement of PDI Reductase Kinetics Using a Fluorescent Disulfide Substrate. [PDF]
Ponzar N, Pozzi N.
europepmc +1 more source
Enhancing blood transfusion safety through RFID-based verification and human factors engineering. [PDF]
Angelucci A +5 more
europepmc +1 more source
Artificial Intelligence in Pancreatic Endoscopic Ultrasonography: From Image-Based Diagnosis to Cytopathology. [PDF]
Merola E +6 more
europepmc +1 more source

